biogen inc (BIIB*:Mexico)
Transactions by BIOGEN INC (BIIB*) in the last 6 months
Biogen Idec Inc. (NasdaqGS:BIIB) agreed to acquire Convergence Pharmaceuticals Limited from Apposite Capital LLP, New Leaf Venture Partners, SV Life Sciences Advisers, LLC and others for approximately $680 million in cash on January 11, 2015. Under the terms of the deal, Biogen Idec will pay Convergence shareholders an upfront payment of $200 million and Convergence shareholders will receive additional payments up to $475 million contingent on future milestones. Convergence ...
Apposite Healthcare Fund
New Leaf Venture Partners, L.L.C.
SV Life Sciences Advisers, LLC
SV Life Sciences Fund V
|Bristol-Myers Squibb Co||$64.67 USD||-0.36|
|Celgene Corp||$108.65 USD||+1.11|
|Eli Lilly & Co||$72.05 USD||+0.14|
|Medtronic PLC||$74.32 USD||-0.59|
|Novo Nordisk A/S||kr364.40 DKK||-2.20|
|View Industry Companies|